Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecanS Sharma, N Kemeny, D P Kelsen, et al.Diseases of the Colon and Rectum|May 1, 1997
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancerA Grann, B D Minsky, A M Cohen, et al.International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancerB D Minsky, A M Cohen, W E Enker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeksS Sharma, N Kemeny, G K Schwartz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumorsL B Saltz, D Spriggs, L J Schaaf, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel studyS J Klempner, R A Pazo-Cid, S Lonardi, et al.The British Journal of Surgery|September 3, 2021
Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinomaE L Vos, R A Carr, M Hsu, et al.Pageof 2